Nurse Practitioner, Family · Schaumburg, IL
NPI
1003563214
Since 2022
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
519 S. Roselle Rd., 2nd Floor-Pulmanary
Schaumburg, IL, 60193
Phone (847) 618-4380
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
450 services
Medicare patients, 2024
322
Average age 78
Drug cost, 2024
$3.8M
1,241 prescriptions
Company payments, 2025
$2,014
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie A Gebhardt was code 99233 (hospital e&m - subsequent), 214 times for 158 patients. In total Julie A Gebhardt billed 450 services in 14 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 214 | 158 | $82.23 | $18K |
| 99214 Office E&M - Established | Office | 125 | 110 | $88.50 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 42 | 36 | $55.18 | $2,318 |
| 99291 Critical Care E&M | Facility | 24 | 19 | $149.43 | $3,586 |
| 99213 Office E&M - Established | Office | 19 | 18 | $63.69 | $1,210 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 12 | 12 | $11.02 | $132 |
By year: 2022 $10K for 131 services; 2023 $38K for 445 services; 2024 $37K for 450 services.
Medicare prescription drug claims, 2024
In 2024, the drug Julie A Gebhardt prescribed most often to Medicare patients was Ofev (Nintedanib Esylate), with 250 prescriptions and refills. In total Julie A Gebhardt wrote 1,241 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofev Nintedanib Esylate | 250 | 250 | 35 | $3.2M |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 134 | 238 | 52 | $148K |
| Prednisone Generic | 132 | 143 | 109 | $513 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 113 | 131 | 60 | $3,094 |
| Azithromycin Generic | 81 | 109 | 58 | $814 |
| Pirfenidone Generic | 36 | 36 | Under 11 | $34K |
| Ipratropium Bromide Generic | 32 | 68 | 18 | $660 |
| Ventolin Hfa Albuterol Sulfate | 32 | 34 | 22 | $2,106 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 31 | 53 | 12 | $25K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 28 | 48 | 12 | $22K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 28 | 34 | 12 | $21K |
| Cefdinir Generic | 27 | 27 | 25 | $350 |
| Doxycycline Hyclate Generic | 26 | 26 | 18 | $253 |
| Montelukast Sodium Generic | 25 | 65 | 14 | $308 |
| Breo Ellipta Fluticasone/Vilanterol | 25 | 39 | Under 11 | $15K |
Brand drugs: 687 claims; generic drugs: 554 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie A Gebhardt $2,014 ($2,014 in general payments such as food, travel and fees) from 8 companies. The largest payer was Genzyme Corporation with $1,048.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.